Miniatura

Fitxers

663904.pdf (297.57 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2014-01-09

Llicència de publicació

cc-by (c) López-Isac, E. et al., 2014
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/115327

A genome wide association study follow-up suggests a possible role of PPARG in systemic esclerosis susceptiblity

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1186/ar4432

Resum

Introduction A recent genome-wide association study (GWAS) comprising a French cohort of systemic sclerosis (SSc) reported several non-HLA single-nucleotide polymorphisms (SNPs) showing a nominal association in the discovery phase. We aimed to identify previously overlooked susceptibility variants by using a follow-up strategy. Methods Sixty-six non-HLA SNPs showing a P value <10-4 in the discovery phase of the French SSc GWAS were analyzed in the first step of this study, performing a meta-analysis that combined data from the two published SSc GWASs. A total of 2,921 SSc patients and 6,963 healthy controls were included in this first phase. Two SNPs, PPARG rs310746 and CHRNA9 rs6832151, were selected for genotyping in the replication cohort (1,068 SSc patients and 6,762 healthy controls) based on the results of the first step. Genotyping was performed by using TaqMan SNP genotyping assays. Results We observed nominal associations for both PPARG rs310746 (PMH = 1.90 × 10-6, OR, 1.28) and CHRNA9 rs6832151 (PMH = 4.30 × 10-6, OR, 1.17) genetic variants with SSc in the first step of our study. In the replication phase, we observed a trend of association for PPARG rs310746 (P value = 0.066; OR, 1.17). The combined overall Mantel-Haenszel meta-analysis of all the cohorts included in the present study revealed that PPARG rs310746 remained associated with SSc with a nominal non-genome-wide significant P value (PMH = 5.00 × 10-7; OR, 1.25). No evidence of association was observed for CHRNA9 rs6832151 either in the replication phase or in the overall pooled analysis.

Matèries

Esclerodèrmia, Malalties autoimmunitàries, Genoma humà

Matèries (anglès)

Scleroderma (Disease), Autoimmune diseases, Human genome

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

LÓPEZ ISAC, Elena, BOSSINI CASTILLO, Lara, SIMEÓN AZNAR, Carmen pilar, EGURBIDE ARBERAS, María victoria, ALEGRE-SANCHO, Juan josé, CALLEJAS RUBIO, José luis, ROMÁN-IVORRA, José andrés, FREIRE, Mayka, BERETTA, Lorenzo, SANTANIELLO, Alessandro, AIRÓ, Paolo, LUNARDI, Claudio, HUNZELMANN, Nicolas, RIEMESTAKEN, Gabriela, WITTE, Torsten, KREUTER, Alexander, DISTLER, Jörg h.v., SCHUERWEGH, Annemie j., VONK, Madelon c., VOSKUYL, Alexandre e., SHIELS, Paul g., VAN LAAR, Jacob m., FONSECA, Carmen, DENTON, Christopher p., HERRICK, Ariane l., WORTHINGTON, Jane, ASSASSI, Shervin, KOELEMAN, Bobby p. c., MAYES, Maureen d., RADSTAKE, Timothy r.d.j., MARTÍN, Javier, ESPINOSA GARRIGA, Gerard, Spanish Scleroderma Study Group (SSSG), NARVÁEZ GARCÍA, Francisco javier. A genome wide association study follow-up suggests a possible role of PPARG in systemic esclerosis susceptiblity. _Arthritis Research & Therapy_. 2014. Vol. 16, núm. 1, pàgs. R6. [consulta: 14 de gener de 2026]. ISSN: 1478-6362. [Disponible a: https://hdl.handle.net/2445/115327]

Exportar metadades

JSON - METS

Compartir registre